This ServiceNow Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Tuesday
This ServiceNow Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Tuesday
這位ServiceNow分析師以看好的態度開始覆蓋；以下是週二的三大啓動對象
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
頂級華爾街分析師改變了他們對這些頂級股票的看法。有關所有分析師評級變動的完整信息，包括評級上調和下調，請查看我們的分析師評級頁面。
- Raymond James analyst Robert Majek initiated coverage on ServiceNow, Inc. (NYSE:NOW) with an Outperform rating and announced a price target of $1200. ServiceNow shares closed at $1,088.26 on Monday. See how other analysts view this stock.
- D. Boral Capital analyst Jason Kolbert initiated coverage on AVITA Medical, Inc. (NASDAQ:RCEL) with a Buy rating and announced a price target of $25. AVITA Medical shares closed at $11.75 on Monday. See how other analysts view this stock.
- LifeSci Capital analyst Cory Jubinville initiated coverage on Mereo BioPharma Group (NASDAQ:MREO) with an Outperform rating and announced a price target of $10. Mereo BioPharma shares closed at $3.39 on Monday. See how other analysts view this stock.
- 雷蒙德·詹姆斯分析師羅伯特·馬傑克對ServiceNow, Inc.（紐交所：NOW）進行了覆蓋，給出了優於大盤的評級，並宣佈目標價爲1200美元。ServiceNow的股票在星期一收盤價爲1088.26美元。看看其他分析師對這隻股票的看法。
- D. Boral Capital分析師傑森·科爾伯特對Avita Medical, Inc.（納斯達克：RCEL）進行了覆蓋，給予買入評級，並宣佈目標價爲25美元。Avita Medical的股票在星期一收盤價爲11.75美元。看看其他分析師對這隻股票的看法。
- LifeSci Capital分析師科裏·朱賓維爾對Mereo BioPharma Group（納斯達克：MREO）進行了覆蓋，給出了優於大盤的評級，並宣佈目標價爲10美元。Mereo BioPharma的股票在星期一收盤價爲3.39美元。看看其他分析師對這隻股票的看法。
Considering buying NOW stock? Here's what analysts think:
考慮購買NOW股票嗎？以下是分析師的想法：
Read This Next:
接下來閱讀：
- How To Earn $500 A Month From Qualcomm Stock
- 如何從高通股票中每月賺取500美元
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間